CD274 and neoplasm: In conclusion, it seems that ZBTB9 was prone to associate with “Cold” TIME, which demonstrated that patients with high ZBTB9 levels might have less infiltration of immune effective cells in the tumor site, and perhaps has a low response to immune checkpoint inhibitors treatment, such as anti-PD1 and anti-PDL1.